[非性精神病发作] [非性精神病发作]
Adrien Verstraete1, Olivier Bodart1
1Service de Neurologie, CHU Liège, Belgique.
Revue medicale de Liege
|June 23, 2023
概括
心理非发作 (PNES) 经常被误诊,因为它们与发作相似. 本综述涵盖PNES流行病学,诊断,治疗和长期不良预后,重点关注传播.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 精神性非发作 (PNES) 模仿发作,但具有不同的病理生理机制.
- 虽然PNES相对比较常见,但却经常被误解,导致诊断和治疗方面的挑战.
研究的目的:
- 简要地回顾当前关于精神性非发作的知识.
- 阐明流行病学数据,诊断方法和PNES的治疗策略.
主要方法:
- 关于精神性非发作的当前文献的综述.
- 强调PNES和发作之间的半生物学差异.
- 讨论治疗干预和沟通策略.
主要成果:
- 关于PNES流行和特征的流行病学数据.
- 关键的诊断特征区分PNES和发作.
- 目前治疗方式及其有效性的概述.
结论:
- 准确诊断PNES至关重要,以避免误诊和治疗错误.
- 有效的管理需要多学科的方法,包括患者和临床医生的沟通.
- 对于PNES患者的长期预后仍然具有挑战性.
相关概念视频
Seizures: Classification
439
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
439
Epilepsy and Seizures: Overview
228
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
228
Antiepileptic Drugs: Sodium Channel Blockers
690
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
690
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Antiepileptic Drugs: Glutamate Antagonists
429
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
429
Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217


